VAD chemotherapy as remission induction for multiple myeloma (Q36080450)

12 August 2017

VAD chemotherapy as remission induction for multiple myeloma (English)

1 reference

12 August 2017

1 reference

Anderson H

1

1 reference

12 August 2017

Scarffe JH

2

1 reference

12 August 2017

Ranson M

3

1 reference

12 August 2017

Young R

4

1 reference

12 August 2017

Wieringa GS

5

1 reference

12 August 2017

Morgenstern GR

6

1 reference

12 August 2017

Fitzsimmons L

7

1 reference

12 August 2017

Ryder D

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 February 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

71

1 reference

12 August 2017

2

1 reference

12 August 2017

326-330

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.65

12 August 2017

0 references

cites work

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033610

Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033610

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033610

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033610

Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033610

Modified adriamycin-vincristine-dexamethasone (m-VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study. The National Cancer Institute of Canada Clinical Trials Group

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033610

SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033610

Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Medical Research Council Working Party for Leukaemia in Adults

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033610

Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033610

Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis

23 September 2018

1 reference

12 December 2020

Treatment of multiple myeloma

1 reference

12 December 2020

High-dose glucocorticoid treatment of resistant myeloma

1 reference

12 December 2020

Multiple myeloma treated with high dose intravenous melphalan

1 reference

12 December 2020

VAD chemotherapy--toxicity and efficacy--in patients with multiple myeloma and other lymphoid malignancies

1 reference

12 December 2020

Intensive treatment of multiple myeloma and criteria for complete remission

1 reference

12 December 2020

Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy

1 reference

12 December 2020

High dose cyclophosphamide, BCNU and VP-16 with autologous blood stem cell support for refractory multiple myeloma

1 reference

12 December 2020

Combination of interferon and dexamethasone in refractory multiple myeloma

1 reference

12 December 2020

Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation

1 reference

12 December 2020

Intensive combined therapy for previously untreated aggressive myeloma

1 reference

12 December 2020

Multiple myeloma: intensified maintenance therapy with recombinant interferon-alpha-2b plus glucocorticoids

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.65

1 reference

12 August 2017

1 reference

12 August 2017

1 reference